product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Human TRAIL/TNFSF10 Antibody
catalog :
MAB687
quantity :
500 ug (also 25 ug)
price :
569 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
75402
reactivity :
human, rat
application :
western blot, immunohistochemistry, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section
more info or order :
citations: 14
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; human
Labovsky V, Martinez L, Davies K, Garcia Rivello H, Calcagno M, Matas A, et al. Association between ligands and receptors related to the progression of early breast cancer in tumor epithelial and stromal cells. Clin Breast Cancer. 2015;15:e13-21 pubmed publisher
  • flow cytometry; human
Stary G, Klein I, Kohlhofer S, Koszik F, Scherzer T, Müllauer L, et al. Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients. Blood. 2009;114:3854-63 pubmed publisher
  • flow cytometry; human
Secchiero P, Lamberti G, Corallini F, Melloni E, Guarnotta C, Sebastiani A, et al. Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye. J Cell Physiol. 2009;218:199-204 pubmed publisher
  • flow cytometry; human
Secchiero P, Melloni E, Corallini F, Beltrami A, Alviano F, Milani D, et al. Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells. Stem Cells. 2008;26:2955-63 pubmed publisher
  • flow cytometry; human
Corallini F, Celeghini C, Rizzardi C, Pandolfi A, Di Silvestre S, Vaccarezza M, et al. Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro. J Cell Physiol. 2007;212:89-95 pubmed
  • flow cytometry; human
Morel J, Audo R, Hahne M, Combe B. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. J Biol Chem. 2005;280:15709-18 pubmed
Liu S, Polsdofer E, Zhou L, Ruan S, Lyu H, Hou D, et al. Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC. Mol Ther Oncolytics. 2021;21:303-314 pubmed publisher
Lima T, Iglesias Gato D, Souza L, Stenvang J, Lima D, Røder M, et al. Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
Dufour F, Rattier T, Constantinescu A, Zischler L, Morlé A, Ben Mabrouk H, et al. TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress. Oncotarget. 2017;8:9974-9985 pubmed publisher
Siegemund M, Pollak N, Seifert O, Wahl K, Hanak K, Vogel A, et al. Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity. Cell Death Dis. 2012;3:e295 pubmed publisher
Zahn S, Rehkämper C, Ferring Schmitt S, Bieber T, Tuting T, Wenzel J. Interferon-? stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus. Br J Dermatol. 2011;165:1118-23 pubmed publisher
Schneider B, Munkel S, Krippner Heidenreich A, Grunwald I, Wels W, Wajant H, et al. Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins. Cell Death Dis. 2010;1:e68 pubmed publisher
Stary G, Bangert C, Tauber M, Strohal R, Kopp T, Stingl G. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J Exp Med. 2007;204:1441-51 pubmed
Campioni D, Secchiero P, Corallini F, Melloni E, Capitani S, Lanza F, et al. Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes. Am J Pathol. 2005;166:557-63 pubmed
product information
master code :
MAB687
SKU :
MAB687
product name :
Human TRAIL/TNFSF10 Antibody
unit size :
500 ug (also 25 ug)
description :
The Human TRAIL/TNFSF10 Antibody from R&D Systems is a mouse monoclonal antibody to TRAIL/TNFSF10. This antibody reacts with human,rat. The Human TRAIL/TNFSF10 Antibody has been validated for the following applications: Flow Cytometry,Western Blot,Immunohistochemistry-Paraffin,Immunocytochemistry,Immunohistochemistry,CyTOF-ready.
target :
TRAIL/TNFSF10
category :
Primary Antibodies
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 ╡m filtered solution in PBS.
clonality :
Monoclonal
clone :
75402
conjugate :
Unconjugated
host :
Mouse
immunogen :
Mouse myeloma cell line NS0-derived recombinant human TRAIL, Thr95-Gly281, Accession # P50591
isotype :
IgG1
purity :
Protein A or G purified from hybridoma culture supernatant
species :
Human,Rat
specificity :
Detects human TRAIL in direct ELISAs.
gene symbol :
TNFSF10
top caption :
Detection of TRAIL/TNFSF10 antibody in Human PBMCs antibody by Flow Cytometry.
accessionNumbers :
P50591
applications :
Flow Cytometry,Western Blot,Immunohistochemistry-Paraffin,Immunocytochemistry,Immunohistochemistry,CyTOF-ready
USD :
569 USD
alt names :
Apo-2 ligand, APO2L, Apo-2Ltumor necrosis factor (ligand) family, member 10, APO2Ltumor necrosis factor apoptosis-inducing ligand splice variant delta, CD253, CD253 antigen, Protein TRAIL, TL2, TNF-related apoptosis-inducing ligand, TNFSF10, TRAILTNF-related apoptosis inducing ligand TRAIL, tumor necrosis factor (ligand) superfamily, member 10, tumor necrosis factor ligand superfamily member 10
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 6 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.